Carlos Lemgruber is currently making significant contributions as a Clinical Supply Chain Study Manager at Sanofi, where he plays a pivotal role in optimizing the supply chain for the Early Development Portfolio in Oncology. In this capacity, Carlos collaborates closely with the Clinical Supply Optimization...
Carlos Lemgruber is currently making significant contributions as a Clinical Supply Chain Study Manager at Sanofi, where he plays a pivotal role in optimizing the supply chain for the Early Development Portfolio in Oncology. In this capacity, Carlos collaborates closely with the Clinical Supply Optimization Specialist to devise and implement tailored supply strategies that ensure the timely delivery of critical materials for clinical trials. His extensive background of over 20 years in supply chain management, coupled with his expertise in warehouse optimization and customer relationship management, positions him as a key asset in navigating the complexities of clinical supply chains.
Carlos's previous experience at Cytiva/Danaher, where he honed his skills in cross-functional team leadership and project management, has equipped him with a robust understanding of the intricacies involved in global supply operations. His tenure at Cytiva, marked by collaboration with teams across multiple locations, including Cranbury (NJ), Marlborough (MA), and Uppsala (Sweden), allowed him to develop a keen insight into the nuances of international supply chain dynamics.
At Sanofi, Carlos is not only focused on forecasting and transportation logistics but is also committed to continuous improvement initiatives that enhance operational efficiency. His strong interpersonal skills and adeptness in contract negotiation further enable him to build lasting relationships with stakeholders, ensuring alignment and success in project execution. As he continues to navigate the evolving landscape of clinical supply chains, Carlos Lemgruber remains dedicated to delivering innovative solutions that support the advancement of oncology therapies and improve patient outcomes.
